Mo Liu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- MicroRNA in disease regulation 5
- Cancer Genomics and Diagnostics 4
-
- Crystal structures of chemical compounds 7
- Co-authors
- Mien‐Chie Hung (9 shared papers)Chun‐Te Chen (5 shared papers)Weiya Xia (7 shared papers)Chia‐Wei Li (2 shared papers)Sumaiyah K. Rehman (2 shared papers)Yan Xiong (2 shared papers)Jennifer L. Hsu (2 shared papers)Chi-Hong Chao (2 shared papers)
- Journals
- Stem Cell Research (5 papers)Nature Cell Biology (3 papers)Virus Genes (2 papers)Journal of Visualized Experiments (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Mo Liu
82 papers receiving 3.4k citations
Mo Liu's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 694
- Oncology 533
- Molecular Biology 1k
- Surgery 673
- Hepatology 127
Countries citing papers authored by Mo Liu
This map shows the geographic impact of Mo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Liu more than expected).
Fields of papers citing papers by Mo Liu
This network shows the impact of papers produced by Mo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Liu. The network helps show where Mo Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mo Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma Hit paper breakdown → | 2017 | 744 |
| 2 | p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs Hit paper breakdown → | 2011 | 646 |
| 3 | 2009 | 362 | |
| 4 | 2011 | 204 | |
| 5 | 2010 | 88 | |
| 6 | Deep whole-genome analysis of 494 hepatocellular carcinomas Hit paper breakdown → | 2024 | 87 |
| 7 | 2011 | 81 | |
| 8 | 2009 | 79 | |
| 9 | 2016 | 79 | |
| 10 | 2019 | 63 | |
| 11 | 2018 | 61 | |
| 12 | 2013 | 53 | |
| 13 | 2019 | 53 | |
| 14 | 2005 | 42 | |
| 15 | 2011 | 41 | |
| 16 | 2005 | 39 | |
| 17 | 2022 | 35 | |
| 18 | 2021 | 33 | |
| 19 | 2011 | 31 | |
| 20 | 2012 | 30 |
About Mo Liu
Mo Liu is a scholar working on Cancer Research, Inorganic Chemistry, Computer Networks and Communications, Hepatology and Molecular Biology, having authored 86 papers that have together received 3.5k indexed citations. Recurring topics across this work include Advanced Database Systems and Queries (9 papers), Crystal structures of chemical compounds (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pluripotent Stem Cells Research (5 papers), MicroRNA in disease regulation (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (694 citations), Oncology (533 citations), Molecular Biology (1k citations), Surgery (673 citations) and Hepatology (127 citations). Mo Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Mien‐Chie Hung, Chun‐Te Chen, Weiya Xia, Chia‐Wei Li, Sumaiyah K. Rehman, Yan Xiong, Jennifer L. Hsu, Chi-Hong Chao, Dihua Yu and Heng‐Huan Lee. Their work appears in journals such as Stem Cell Research, Nature Cell Biology, Virus Genes, Journal of Visualized Experiments and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.